Abbott

By Brendan Pierson (Reuters) -Abbott and Reckitt unit Mead Johnson are not responsible for a young boy’s debilitating intestinal disease, a jury found on Thursday in a lawsuit accusing them of failing to warn of their premature baby formulas’ risks. The ruling is a victory for the two companies following…

By Brendan Pierson (Reuters) -A lawyer for a Missouri mother on Wednesday asked a jury to make Abbott and Reckitt’s Mead Johnson pay a total of more than $6 billion in the latest trial over claims that the companies’ formulas for premature babies caused a severe intestinal illness. Litigation over…

By Brendan Pierson (Reuters) – A Missouri mother and her lawyers this week will aim to convince a jury that Abbott, Reckitt’s Mead Johnson and St. Louis Children’s Hospital are responsible for a severe intestinal illness that she says her premature son got from the companies’ formulas after he was…

Abbott Laboratories (NYSE:) reported first-quarter adjusted earnings per share of $0.98, surpassing analyst consensus estimates and showcasing a robust start to the year. The healthcare giant also increased its full-year adjusted earnings guidance to a range of $4.55 to $4.70, while forecasting organic sales growth, excluding COVID testing, between 8.5%…